User login
Back to top


Displaying 37 results from 37 total publications.

Lamb et al. 2021.

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort

Maxine JE Lamb,  Alexandra Smith,  Daniel Painter,  Eleanor Kane,  Timothy Bagguley,  Robert Newton,  Debra Howell,  Gordon Cook,  Ruth de Tute,  Andrew Rawstron,  Russell Patmore,  Eve Roman.

BMJ Open
Volume: 11, Issue: 2, Pages: e041296.

Lacy et al. 2020.

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

Stuart E. Lacy,  Sharon L. Barrans,  Philip A. Beer,  Daniel Painter,  Alexandra G. Smith,  Eve Roman,  Susanna L. Cooke,  Camilo Ruiz,  Paul Glover,  Suzan J. L. Van Hoppe,  Nichola Webster,  Peter J. Campbell,  Reuben M. Tooze,  Russell Patmore,  Cathy Burton,  Simon Crouch,  Daniel J. Hodson.

Volume: 135, Issue: 20, Pages: 1759-1771.

Sheridan et al. 2020.

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network

Rebecca Sheridan,  Eve Roman,  Alex G. Smith,  Andrew Turner,  Anne C. Garry,  Russell Patmore,  Martin R. Howard,  Debra A. Howell.

BMJ Supportive & Palliative Care

Cucco et al. 2019.

Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit

Francesco Cucco,  Sharon Barrans,  Chulin Sha,  Alexandra Clipson,  Simon Crouch,  Rachel Dobson,  Zi Chen,  Joe Sneath Thompson,  Matthew A. Care,  Thomas Cummin,  Josh Caddy,  Hongxiang Liu,  Anne Robinson,  Anna Schuh,  Jude Fitzgibbon,  Daniel Painter,  Alexandra Smith,  Eve Roman,  Reuben Tooze,  Catherine Burton,  Andrew J. Davies,  David R. Westhead,  Peter W. M. Johnson,  Ming-Qing Du.


Lamb et al. 2019.

Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network

Maxine JE Lamb,  Eve Roman,  Debra A. Howell,  Eleanor Kane,  Timothy Bagguley,  Cathy Burton,  Russell Patmore,  Alexandra G. Smith.

Volume: 3, Issue: 4.

Kane et al. 2019.

Risk of mature B-cell neoplasms and precursor conditions after joint replacement: a report from the Haematological Malignancy Research Network

Eleanor Kane,  Daniel Painter,  Alexandra Smith,  Maxine Lamb,  Steven E. Oliver,  Russell Patmore,  Eve Roman.

International Journal of Cancer

Rosenwald et al. 2019.

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

Andreas Rosenwald,  Susanne Bens,  Ranjana Advani,  Sharon Barrans,  Christiane Copie-Bergman,  Mad-Helenie Elsensohn,  Yaso Natkunam,  Maria Calaminici,  Birgitta Sander,  Maryse Baia,  Alexandra Smith,  Daniel Painter,  Luu Pham,  Shuchun Zhao,  Marita Ziepert,  Ekaterina S. Jordanova,  Thierry J. Molina,  Marie José Kersten,  Eva Kimby,  Wolfram Klapper,  John Raemaekers,  Norbert Schmitz,  Fabrice Jardin,  Wendy B. C. Stevens,  Eva Hoster,  Anton Hagenbeek,  John G. Gribben,  Reiner Siebert,  Randy D. Gascoyne,  David W. Scott,  Philippe Gaulard,  Gilles Salles,  Catherine Burton,  Daphne de Jong,  Laurie H. Sehn,  Delphine Maucort-Boulch.

Journal of Clinical Oncology

Wilson et al. 2019.

Frontline management of nodular lymphocyte predominant Hodgkin lymphoma – a retrospective UK multicentre study

Matthew R. Wilson,  Timothy Bagguley,  Alexandra Smith,  Eve Roman,  Russell Patmore,  Katharine Hanlon,  Mike Leach,  Mark Bishton,  Cathy Burton,  Pam McKay.

British Journal of Haematology
Volume: 186, Issue: 6, Pages: 214-217.

Kane et al. 2019.

The impact of rheumatological disorders on lymphomas and myeloma : a report on risk and survival from the UK's population-based Haematological Malignancy Research Network

Eleanor Kane,  Daniel Painter,  Alexandra Smith,  Simon Crouch,  Steven Oliver,  Russell Patmore,  Eve Roman.

Cancer Epidemiology
Pages: 236-243.

Cargo et al. 2019.

The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis

Catherine Cargo,  Matthew Cullen,  Jan Taylor,  Mike Short,  Paul Glover,  Suzan Van Hoppe,  Alex Smith,  Paul Evans,  Simon Crouch.

Pages: blood-2018-08-867333.

McCulloch et al. 2018.

Receiving treatment at a specialist centre confers an overall survival benefit for patients with mantle cell lymphoma

Rory McCulloch,  Alexandra Smith,  Nicola Crosbie,  Russell Patmore,  Simon Rule.

British Journal of Haematology
Volume: 0, Issue: 0.

Wang et al. 2018.

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data

Han-I Wang,  Eve Roman,  Simon Crouch,  Eline Aas,  Cathy Burton,  Russell Patmore,  Alexandra Smith.

Value in Health

Smith et al. 2018.

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)

Alexandra Smith,  Eve Roman,  Simon Appleton,  Debra Howell,  Rod Johnson,  Cathy Burton,  Russell Patmore.

British Journal of Haematology
Volume: 181, Issue: 2, Pages: 215-228.

Painter et al. 2018.

Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based Haematological Malignancy Research Network

Daniel Painter,  Sharon Barrans,  Stuart Lacy,  Alexandra Smith,  Simon Crouch,  David Westhead,  Chulin Sha,  Russell Patmore,  Reuben Tooze,  Cathy Burton,  Eve Roman.

British Journal of Haematology

Kane et al. 2017.

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network

Eleanor Kane,  Debra Howell,  Alexandra Smith,  Simon Crouch,  Cathy Burton,  Eve Roman,  Russell Patmore.

European Journal of Cancer (Oxford, England: 1990)
Volume: 78, Pages: 53-60.

Wang et al. 2017.

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort

Han-I. Wang,  Alexandra Smith,  Eline Aas,  Eve Roman,  Simon Crouch,  Cathy Burton,  Russell Patmore.

The European Journal of Health Economics
Volume: 18, Issue: 2, Pages: 255-267.

Howell et al. 2017.

Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a UK population-based study

Debra Howell,  Alexandra Smith,  Simon Appleton,  Timothy Bagguley,  Una Macleod,  Gordon Cook,  Russell Patmore,  Eve Roman.

British Journal of Haematology
Volume: 177, Issue: 1, Pages: 67-71.

Li et al. 2016.

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN)

Jinlei Li,  Alex Smith,  Simon Crouch,  Steven Oliver,  Eve Roman.

Cancer Causes & Control
Volume: 27, Issue: 8, Pages: 1-8.

Roman et al. 2016.

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15

Eve Roman,  Alex Smith,  Simon Appleton,  Simon Crouch,  Richard Kelly,  Sally Kinsey,  Catherine Cargo,  Russell Patmore.

Cancer Epidemiology
Volume: 42, Pages: 186-198.

Cargo et al. 2015.

Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression

Catherine A. Cargo,  Nicola Rowbotham,  Paul A. Evans,  Sharon L. Barrans,  David T. Bowen,  Simon Crouch,  Andrew S. Jack.

Volume: 126, Issue: 21, Pages: 2362-2365.

Howell et al. 2015.

Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma

Debra A. Howell,  Fiona Warburton,  Amanda-Jane Ramirez,  Eve Roman,  Alexandra G. Smith,  Lindsay J. L. Forbes.

British Journal of Cancer
Volume: 113, Pages: 1114-1120.

Smith et al. 2015.

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma

Alexandra Smith,  Simon Crouch,  Debra Howell,  Cathy Burton,  Russell Patmore,  Eve Roman.

Cancer Epidemiology
Volume: 39, Issue: 6, Pages: 1103-1112.

Howell et al. 2015.

Preferred and actual place of death in haematological malignancy

D. A. Howell,  H. I. Wang,  E. Roman,  A. G. Smith,  R. Patmore,  M. J. Johnson,  A. Garry,  M. Howard.

BMJ Supportive & Palliative Care
Volume: 7, Pages: 150-157.

Painter et al. 2015.

The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients

Dan Painter,  Alexandra Smith,  Ruth de Tute,  Simon Crouch,  Eve Roman,  Andrew Jack.

British Journal of Haematology
Volume: 170, Issue: 2, Pages: 175-178.

Smith et al. 2015.

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network

A. Smith,  S. Crouch,  S. Lax,  J. Li,  D. Painter,  D. Howell,  R. Patmore,  A. Jack,  E. Roman.

British Journal of Cancer
Volume: 112, Issue: 9, Pages: 1575-1584.

Clipson et al. 2015.

The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit

Alexandra Clipson,  Sharon Barrans,  Naiyan Zeng,  Simon Crouch,  Nicholas F Grigoropoulos,  Hongxiang Liu,  Sylvia Kocialkowski,  Ming Wang,  Yuanxue Huang,  Lisa Worrillow,  John Goodlad,  Jenny Buxton,  Michael Neat,  Paul Fields,  Bridget Wilkins,  John W Grant,  Penny Wright,  Hesham EI-Daly,  George A Follows,  Eve Roman,  A James Watkins,  Peter W M Johnson,  Andrew Jack,  Ming-Qing Du.

The Journal of Pathology: Clinical Research
Volume: 1, Issue: 3, Pages: 125-133.

Wang et al. 2014.

Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model

Han-I Wang,  Eline Aas,  Debra Howell,  Eve Roman,  Russell Patmore,  Andrew Jack,  Alexandra Smith.

Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research
Volume: 17, Issue: 2, Pages: 205-214.

Howell et al. 2014.

Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma

D. A. Howell,  H.-I. Wang,  E. Roman,  A. G. Smith,  R. Patmore,  M. J. Johnson,  A. C. Garry,  M. R. Howard.

BMJ supportive & palliative care
Volume: 5, Pages: 496-502.

Crouch et al. 2014.

Determining disease prevalence from incidence and survival using simulation techniques

Simon Crouch,  Alex Smith,  Dan Painter,  Jinlei Li,  Eve Roman.

Cancer Epidemiology
Volume: 38, Issue: 2, Pages: 193-199.

Smith et al. 2014.

Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort

A. G. Smith,  D. Painter,  D. A. Howell,  P. Evans,  G. Smith,  R. Patmore,  A. Jack,  E. Roman.

BMJ open
Volume: 4, Issue: 1, Pages: e004266.

Howell et al. 2013.

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network

Debra A. Howell,  Alexandra G. Smith,  Andrew Jack,  Russell Patmore,  Una Macleod,  Emma Mironska,  Eve Roman.

BMC Hematology
Volume: 13, Issue: 1, Pages: 9.

Howell et al. 2013.

Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death

Debra A Howell,  Han-I Wang,  Alexandra G Smith,  Martin R Howard,  Russell D Patmore,  Eve Roman.

BMC Palliative Care
Volume: 12, Issue: 1, Pages: 42.

Barrans et al. 2012.

Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome

S.L. Barrans,  S. Crouch,  M.A. Care,  L. Worrillow,  A. Smith,  R. Patmore,  D.R. Westhead,  R. Tooze,  E. Roman,  A.S. Jack.

British Journal of Haematology
Volume: 159, Issue: 4, Pages: 441-453.

Smith et al. 2011.

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network

A. Smith,  D. Howell,  R. Patmore,  A. Jack,  E. Roman.

British Journal of Cancer
Volume: 105, Issue: 11, Pages: 1684-1692.

Roman and Smith 2011.

Epidemiology of lymphomas

E. Roman,  A.G. Smith.

Volume: 58, Issue: 1, Pages: 4-14.

Barrans et al. 2010.

Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab

S. Barrans,  S. Crouch,  A. Smith,  K. Turner,  R. Owen,  R. Patmore,  E. Roman,  A. Jack.

Journal of Clinical Oncology
Volume: 28, Issue: 10, Pages: 3360-3365.

Ansell et al. 2007.

What determines referral of UK patients with haematological malignancies to palliative care services? An exploratory study using hospital records

P. Ansell,  D. Howell,  A. Garry,  S. Kite,  J. Munro,  E. Roman,  M. Howard.

Palliative Medicine
Volume: 21, Issue: 6, Pages: 487-492.